In this section:

Bringing new innovative therapies to the people who need them.

We are advancing our innovative therapies, based on our next-generation proprietary AAV platform technology.

Our proprietary platform technology includes a novel AAV capsid, which enables high levels of expressed protein, making it possible for gene therapy to potentially address a broad range of diseases.

We are looking for talented people to join the team